This information was provided by prnewswire
Send your Press Release here.
TORONTO, Oct. 18 2018 /CNW/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com (“Liberty” or the “Company”), a provider of high quality cannabis, announced today that they have been awarded a Processor provisional license by the Ohio Department of Commerce. Liberty, along with their Ohio-based joint venture partner, the Schottenstein Group, will work on securing a Certificate of Operation over the next several months. The Processor provisional license follows the awarding of the Provisional dispensary license in June 2018 in the city of Dayton. Liberty owns 50.1% of both the Processor provisional license and the Provisional dispensary license with the Schottenstein Group owning the remaining 49.9%.
“We are extremely pleased to be able to bring our high-quality medical cannabis processing methods to the citizens of Ohio,” said George Scorsis, CEO of Liberty Health Sciences. “The state of Ohio represents a great opportunity for Liberty with our approach to providing quality product for patients in need. The list of approved conditions in the state under the medical cannabis program, results in a large potential patient base for Liberty.”
Liberty currently processes a full range of products in their Florida operations ranging from tinctures to capsules and where it has established a track record for consistent high quality product for medical patients. Liberty will bring these same methods to Ohio and products to the extent that they are allowed for under the Ohio regulations.
“Our consumer is central to everything we do,” said George Scorsis. “Our priority is to provide the best possible solution to our patients which requires Liberty to be able to offer a full range of cannabis products to suit our customer’s specific needs. Our goal is for patients continue to come back to Liberty because of the consistent and dependable products we offer.”
Leave a Reply